Skip to main content
British Medical Journal logoLink to British Medical Journal
. 1953 Jan 10;1(4801):59–64. doi: 10.1136/bmj.1.4801.59

Triethylene Melamine in Human Malignant Disease

Edith Paterson, P B Kunkler, A L Walpole
PMCID: PMC2015219  PMID: 12997844

Full text

PDF
59

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ACTION of certain ethylenimine (aziridine) derivatives on mouse leukemia. Arch Biochem. 1950 Apr;26(2):321–323. [PubMed] [Google Scholar]
  2. HENDRY J. A., HOMER R. F., ROSE F. L., WALPOLE A. L. Cytotoxic agents: III, derivatives of ethyleneimine. Br J Pharmacol Chemother. 1951 Sep;6(3):357–410. doi: 10.1111/j.1476-5381.1951.tb00650.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. KARNOFSKY D. A., BURCHENAL J. H., ARMISTEAD G. C., Jr, SOUTHAM C. M., BERNSTEIN J. L., CRAVER L. F., RHOADS C. P. Triethylene melamine in the treatment of neoplastic disease; a compound with nitrogen-mustardlike activity suitable for oral and intravenous use. AMA Arch Intern Med. 1951 Apr;87(4):477–516. doi: 10.1001/archinte.1951.03810040002001. [DOI] [PubMed] [Google Scholar]
  4. RETARDATION of tumor growth in mice by oral administration of ethylenimine derivatives. Arch Biochem. 1950 Apr;26(2):319–320. [PubMed] [Google Scholar]
  5. ROSE F. L., HENDRY J. A., WALPOLE A. L. New cytotoxic agents with tumour-inhibitory activity. Nature. 1950 Jun 24;165(4208):993–996. doi: 10.1038/165993a0. [DOI] [PubMed] [Google Scholar]

Articles from British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES